The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Practical management of peripartum cardiomyopathy

  • Kim, Mi-Jeong (Division of Cardiology, Department of Internal Medicine, College of Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea) ;
  • Shin, Mi-Seung (Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center)
  • Received : 2016.10.03
  • Accepted : 2017.03.17
  • Published : 2017.05.01
⟨ Previous Next ⟩

Abstract

Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy that causes systolic heart failure (HF) in previously healthy young women. Despite latest remarkable achievement, unifying pathophysiologic mechanism is not well established. Considering close temporal relationship to pregnancy, the recent prolactin theory is promising. Abnormal short form of 16-kDa prolactin may be produced in the oxidative stress milieu, show anti-angiogenic effect and damage cardiovascular structure in late pregnancy. Future study is needed to determine whether abnormal prolactin system is useful as a biomarker for diagnosis and therapy of PPCM. Diagnosis is made based on the finding of left ventricular systolic dysfunction after excluding other causes of HF. A multidisciplinary team approach is essential for acute HF, antepartum, labor and postpartum care. Recovery from left ventricular dysfunction is critical for prognosis. As PPCM can recur and cause serious clinical events, subsequent pregnancy is not recommended. This review focuses on the practical management of PPCM.

Keywords

References

  1. Sliwa K, Bohm M. Incidence and prevalence of pregnancy-related heart disease. Cardiovasc Res 2014;101:554-560. https://doi.org/10.1093/cvr/cvu012
  2. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-778. https://doi.org/10.1093/eurjhf/hfq120
  3. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015;36:1090-1097. https://doi.org/10.1093/eurheartj/ehv009
  4. Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovasc Res 2014;101:561-570. https://doi.org/10.1093/cvr/cvu013
  5. Kim MJ, Seo J, Cho KI, Yoon SJ, Choi JH, Shin MS. Echocardiographic assessment of structural and hemodynamic changes in hypertension-related pregnancy. J Cardiovasc Ultrasound 2016;24:28-34. https://doi.org/10.4250/jcu.2016.24.1.28
  6. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
  7. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 1995;129:421-422. https://doi.org/10.1016/0002-8703(95)90032-2
  8. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169-2175. https://doi.org/10.1161/CIRCULATIONAHA.109.929646
  9. Ware JS, Li J, Mazaika E, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 2016;374:233-241. https://doi.org/10.1056/NEJMoa1505517
  10. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-928. https://doi.org/10.1161/01.CIR.81.3.922
  11. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363-365. https://doi.org/10.1016/j.ajog.2005.01.022
  12. Sliwa K, Forster O, Libhaber E, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27:441-446. https://doi.org/10.1093/eurheartj/ehi481
  13. Patten IS, Rana S, Shahul S, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012;485:333-338. https://doi.org/10.1038/nature11040
  14. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600. https://doi.org/10.1016/j.cell.2006.12.036
  15. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-693. https://doi.org/10.1016/S0140-6736(06)69253-2
  16. Fett JD, Christie LG, Carraway RD, Ansari AA, Sundstrom JB, Murphy JG. Unrecognized peripartum cardiomyopathy in Haitian women. Int J Gynaecol Obstet 2005;90:161-166. https://doi.org/10.1016/j.ijgo.2005.05.004
  17. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-3197. https://doi.org/10.1093/eurheartj/ehr218
  18. Halkein J, Tabruyn SP, Ricke-Hoch M, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest 2013;123:2143-2154. https://doi.org/10.1172/JCI64365
  19. Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010;56:1247-1253. https://doi.org/10.1016/j.jacc.2010.02.076
  20. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999;94:311-316.
  21. Kim EK, Chang SA, Choi JO, et al. Concordant and discordant cardiac magnetic resonance imaging delayed hyperenhancement patterns in patients with ischemic and non-ischemic cardiomyopathy. Korean Circ J 2016;46:41-47. https://doi.org/10.4070/kcj.2016.46.1.41
  22. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009;54:1407-1424. https://doi.org/10.1016/j.jacc.2009.04.094
  23. Kawano H, Tsuneto A, Koide Y, et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern Med 2008;47:97-102. https://doi.org/10.2169/internalmedicine.47.0316
  24. Beckett KR, Moriarity AK, Langer JM. Safe use of contrast media: what the radiologist needs to know. Radiographics 2015;35:1738-1750. https://doi.org/10.1148/rg.2015150033
  25. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-1061. https://doi.org/10.1161/01.CIR.44.6.1053
  26. Pearson GD, Veille JC, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183-1188. https://doi.org/10.1001/jama.283.9.1183
  27. Grewal J, Siu SC, Ross HJ, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2009;55:45-52. https://doi.org/10.1016/j.jacc.2009.08.036
  28. Lee HY, Chung WJ, Jeon HK, et al. Impact of the beta-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between beta adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Korean J Intern Med 2016;31:277-287. https://doi.org/10.3904/kjim.2015.043
  29. Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010;121:1465-1473. https://doi.org/10.1161/CIRCULATIONAHA.109.901496
  30. Haghikia A, Podewski E, Berliner D, et al. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy. Clin Res Cardiol 2015;104:911-917. https://doi.org/10.1007/s00392-015-0869-5
  31. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869. https://doi.org/10.1093/eurjhf/hfs105
  32. Rasmusson K, Brunisholz K, Budge D, et al. Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant 2012;31:180-186. https://doi.org/10.1016/j.healun.2011.11.018
  33. Dinic V, Markovic D, Savic N, Kutlesic M, Jankovic RJ. Peripartum cardiomyopathy in intensive care unit: an update. Front Med (Lausanne) 2015;2:82.
  34. Ruys TP, Cornette J, Roos-Hesselink JW. Pregnancy and delivery in cardiac disease. J Cardiol 2013;61:107-112. https://doi.org/10.1016/j.jjcc.2012.11.001
  35. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 2000;35:701-705. https://doi.org/10.1016/S0735-1097(99)00624-5
  36. Goland S, Modi K, Bitar F, et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 2009;15:645-650. https://doi.org/10.1016/j.cardfail.2009.03.008
  37. McNamara DM, Elkayam U, Alharethi R, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015;66:905-914. https://doi.org/10.1016/j.jacc.2015.06.1309
  38. Fett JD, Christie LG, Carraway RD, Murphy JG. Fiveyear prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005;80:1602-1606. https://doi.org/10.4065/80.12.1602
  39. Carvalho A, Brandao A, Martinez EE, et al. Prognosis in peripartum cardiomyopathy. Am J Cardiol 1989;64:540-542. https://doi.org/10.1016/0002-9149(89)90438-4
  40. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-1084. https://doi.org/10.1056/NEJM200004133421502
  41. Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-1571. https://doi.org/10.1056/NEJM200105243442101
  42. Brar SS, Khan SS, Sandhu GK, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 2007;100:302-304. https://doi.org/10.1016/j.amjcard.2007.02.092
  43. Duran N, Gunes H, Duran I, Biteker M, Ozkan M. Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 2008;101:137-140. https://doi.org/10.1016/j.ijgo.2007.11.007
  44. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 2003;102:1326-1331.
  45. Bouabdallaoui N, Mouquet F, Lebreton G, Demondion P, Le Jemtel TH, Ennezat PV. Current knowledge and recent development on management of peripartum cardiomyopathy. Eur Heart J Acute Cardiovasc Care. 2015 Oct 16 [Epub]. http://doi.org/10.1177/2048872615612465.
  46. Fett JD, Sannon H, Thelisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. Int J Gynaecol Obstet 2009;104:125-127. https://doi.org/10.1016/j.ijgo.2008.09.017
  47. Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014;64:1629-1636. https://doi.org/10.1016/j.jacc.2014.07.961
  48. Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 2008;199:415.e1-415.e5. https://doi.org/10.1016/j.ajog.2008.06.087

Cited by

  1. Role of pregnancy hormones and hormonal interaction on the maternal cardiovascular system: a literature review vol.108, pp.8, 2019, https://doi.org/10.1007/s00392-019-01441-x
  2. Successful pregnancy with left ventricular assist device failure in the setting of peripartum cardiomyopathy vol.35, pp.1, 2017, https://doi.org/10.1080/08998280.2021.1967020